Eyegate Pharmaceuticals Stock Forecast

Hold candidate since Jun 23, 2026

The EyeGate Pharmaceuticals Inc stock price gained 0.131% on the last trading day (Tuesday, 23rd Jun 2026), rising from $35.23 to $35.28. During the last trading day the stock fluctuated 0% from a day low at $35.28 to a day high of $35.28. The price has risen in 6 of the last 10 days and is up by 0.66% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 18 more shares were traded than the day before. In total, 25 shares were bought and sold for approximately $881.88 .

The stock is moving within a narrow and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect EyeGate Pharmaceuticals Inc stock with a 90% probability to be traded between $34.63 and $35.40 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

EYEG Signals & Forecast

The EyeGate Pharmaceuticals Inc stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $35.28. On a fall, the stock will find some support from the long-term average at approximately $35.21. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. EyeGate Pharmaceuticals Inc has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Friday, May 29, 2026, and so far it has fallen -0.424%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). The stock had a Golden Star Signal on Friday, June 12, 2026 in the short-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Support, Risk & Stop-loss for EyeGate Pharmaceuticals Inc stock

EyeGate Pharmaceuticals Inc finds support from accumulated volume at $35.25 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 0.0028%.

Our recommended stop-loss: $33.85 (-4.03%) (This stock has very low daily movements and this gives very low risk. There is a sell signal from a pivot top found 16 days ago.)

Trading Expectations (EYEG) For The Upcoming Trading Day Of Wednesday 24th

For the upcoming trading day on Wednesday, 24th we expect EyeGate Pharmaceuticals Inc to open at $35.28, and during the day (based on 14 day Average True Range), to move between $35.23 and $35.32, which gives a possible trading interval of +/-$0.0837 (+/-0.24%) up or down from last closing price. If EyeGate Pharmaceuticals Inc takes out the full calculated possible swing range there will be an estimated 0.24% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $35.25 (0.09%) than the resistance at $35.51 (0.67%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is EyeGate Pharmaceuticals Inc stock A Buy?

EyeGate Pharmaceuticals Inc holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.

Current score: 0.083 Hold/Accumulate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 24, 2026 - $35.28 ( 0%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk